Email me when Versant Venture Management, LLC files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Date Filed |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | 9 | $212M | +$124M | -$22.7M | +$101M | LENZ, GLUE, JBIO, CRSP, SKYE | 13F-HR | 11/10/2025, 04:48 PM |
| Q2 2025 | 8 | $82.1M | +$17.1M | -$4.08M | +$13M | GLUE, CRSP, JBIO, SKYE, RPTX | 13F-HR | 8/11/2025, 04:35 PM |
| Q1 2025 | 7 | $60.2M | +$2.59M | -$2.93M | -$338K | GLUE, CRSP, CTNM, SKYE, RPTX | 13F-HR | 5/7/2025, 04:24 PM |
| Q4 2024 | 7 | $86.7M | +$42.2M | -$2.07M | +$40.1M | GLUE, CRSP, CTNM, SKYE, RPTX | 13F-HR | 2/11/2025, 06:03 PM |
| Q3 2024 | 6 | $63.6M | $0 | -$3.71M | -$3.71M | CRSP, CTNM, RPTX, SKYE, ADVM | 13F-HR | 11/8/2024, 05:18 PM |
| Q2 2024 | 8 | $77.3M | +$16.2M | -$1.04M | +$15.1M | CRSP, CTNM, SKYE, RPTX, ADVM | 13F-HR | 8/7/2024, 04:16 PM |
| Q1 2024 | 7 | $103M | +$31.4M | -$385M | -$354M | CRSP, SKYE, RPTX, GRTS, ADVM | 13F-HR | 5/3/2024, 04:35 PM |
| Q4 2023 | 7 | $389M | $0 | -$275K | -$275K | RYZB, CRSP, RPTX, GRTS, PASG | 13F-HR | 2/8/2024, 05:05 PM |
| Q3 2023 | 8 | $188M | +$115M | -$11.2M | +$103M | RYZB, RPTX, CRSP, ADVM, GRTS | 13F-HR | 11/3/2023, 05:10 PM |
| Q2 2023 | 8 | $84.3M | +$28M | $0 | +$28M | RPTX, CRSP, ADVM, GRTS, CBAY | 13F-HR | 8/9/2023, 04:55 PM |
| Q1 2023 | 7 | $48M | $0 | $0 | CRSP, GRTS, PASG, CBAY, ADVM | 13F-HR | 5/10/2023, 07:11 PM | |
| Q4 2022 | 7 | $48.3M | $0 | -$121K | -$121K | CRSP, GRTS, PASG, CBAY, ADVM | 13F-HR | 2/9/2023, 04:13 PM |
| Q3 2022 | 8 | $52.5M | $0 | $0 | CRSP, GRTS, ADVM, ALGS, CBAY | 13F-HR | 11/10/2022, 04:35 PM | |
| Q2 2022 | 8 | $65.2M | $0 | -$17.8M | -$17.8M | CRSP, PASG, GRTS, ADVM, UTRS | 13F-HR | 8/11/2022, 04:05 PM |
| Q1 2022 | 10 | $100M | $0 | $0 | CRSP, PASG, GRTS, CRNX, AKRO | 13F-HR | 5/10/2022, 04:25 PM | |
| Q4 2021 | 10 | $187M | +$8.6M | -$29.9M | -$21.3M | GRTS, CRSP, PASG, ALGS, AKRO | 13F-HR | 2/11/2022, 06:05 AM |
| Q3 2021 | 11 | $242M | $0 | -$5.92M | -$5.92M | CRSP, PASG, GRTS, ALGS, CRNX | 13F-HR | 11/12/2021, 04:30 PM |
| Q2 2021 | 11 | $302M | $0 | -$215M | -$215M | CRSP, PASG, ALGS, GRTS, ADVM | 13F-HR | 8/12/2021, 04:17 PM |
| Q1 2021 | 11 | $513M | +$87.3M | -$440M | -$353M | CRSP, PASG, ALGS, ADVM, GRTS | 13F-HR | 5/6/2021, 05:45 PM |
| Q4 2020 | 12 | $963M | +$297M | -$130M | +$167M | CRSP, NARI, ALGS, ADVM, FLXN | 13F-HR | 2/16/2021, 07:30 AM |
| Q3 2020 | 11 | $546M | +$40M | -$127M | -$87.3M | CRSP, ADVM, APRE, FLXN, CRNX | 13F-HR | 11/12/2020, 05:07 PM |
| Q2 2020 | 12 | $696M | +$116M | -$18.5M | +$97.8M | CRSP, ADVM, APRE, AKRO, CRNX | 13F-HR | 7/20/2020, 02:14 PM |
| Q1 2020 | 9 | $365M | +$127M | -$3.91M | +$123M | CRSP, ADVM, AKRO, VCYT, GRTS | 13F-HR | 4/28/2020, 12:36 PM |
| Q4 2019 | 7 | $332M | $0 | -$17.3M | -$17.3M | CRSP, VCYT, GRTS, OCUL, EYES | 13F-HR | 1/21/2020, 03:12 PM |
| Q3 2019 | 8 | $258M | $0 | -$29.6M | -$29.6M | CRSP, VCYT, GRTS, BOLD, OCUL | 13F-HR | 10/8/2019, 02:24 PM |
| Q2 2019 | 9 | $343M | +$34.6M | -$48.3M | -$13.7M | CRSP, VCYT, GRTS, BOLD, OCUL | 13F-HR | 7/12/2019, 06:05 AM |
| Q1 2019 | 9 | $304M | +$22.9M | -$18.5M | +$4.32M | CRSP, VCYT, BOLD, CBAY, OCUL | 13F-HR | 4/5/2019, 02:25 PM |
| Q4 2018 | 10 | $202M | $0 | $0 | CRSP, VCYT, BOLD, OCUL, CBAY | 13F-HR | 1/22/2019, 04:53 PM | |
| Q3 2018 | 10 | $294M | +$34.9M | $0 | +$34.9M | CRSP, BOLD, VCYT, OCUL, CBAY | 13F-HR | 10/5/2018, 04:19 PM |
| Q2 2018 | 9 | $321M | +$182K | -$58.6M | -$58.4M | CRSP, BOLD, OCUL, CBAY, AKAOQ | 13F-HR | 7/13/2018, 03:40 PM |
| Q1 2018 | 8 | $313M | +$211M | $0 | +$211M | CRSP, BOLD, AKAOQ, OCUL, CBAY | 13F-HR | 5/3/2018, 04:43 PM |
| Q4 2017 | 7 | $95M | $0 | -$19.6M | -$19.6M | BOLD, AKAOQ, OCUL, CBAY, IMDZ | 13F-HR | 1/25/2018, 02:57 PM |
| Q3 2017 | 8 | $131M | $0 | $0 | BOLD, IMDZ, AKAOQ, OCUL, CLVSQ | 13F-HR | 10/13/2017, 11:52 AM | |
| Q2 2017 | 8 | $127M | $0 | -$28.6M | -$28.6M | BOLD, AKAOQ, IMDZ, OCUL, CLVSQ | 13F-HR | 8/2/2017, 12:13 PM |
| Q1 2017 | 8 | $138M | +$8.37M | -$2.45M | +$5.92M | AKAOQ, BOLD, CLVSQ, OCUL, IMDZ | 13F-HR | 4/7/2017, 01:59 PM |
| Q4 2016 | 7 | $103M | $0 | $0 | BOLD, OCUL, CLVSQ, AKAOQ, IMDZ | 13F-HR | 1/18/2017, 02:47 PM | |
| Q3 2016 | 7 | $89.7M | +$48.9M | -$94.9M | -$46M | BOLD, IMDZ, OCUL, CLVSQ, AKAOQ | 13F-HR | 10/24/2016, 06:01 AM |
| Q2 2016 | 5 | $98.7M | $0 | -$67.5M | -$67.5M | GKOS, OCUL, CLVSQ, AKAOQ, CBAY | 13F-HR | 7/28/2016, 04:21 PM |
| Q1 2016 | 7 | $139M | $0 | $0 | GKOS, FPRX, OCUL, CLVSQ, BITI | 13F-HR | 4/25/2016, 02:10 PM | |
| Q4 2015 | 7 | $171M | $0 | -$148K | -$148K | GKOS, FPRX, OCUL, CLVSQ, AKAOQ | Restatement | 5/5/2016, 01:15 PM |
| Q3 2015 | 7 | $174M | +$107M | $0 | +$107M | GKOS, CLVSQ, OCUL, FPRX, AKAOQ | 13F-HR | 10/28/2015, 01:33 PM |
| Q2 2015 | 5 | $78.8M | +$5.37M | -$44.3M | -$38.9M | CLVSQ, FPRX, AKAOQ, BITI, CBAY | 13F-HR | 7/15/2015, 03:38 PM |
| Q1 2015 | 6 | $114M | +$4.97M | $0 | +$4.97M | CLVSQ, FPRX, AKAOQ, CBAY, INGN | 13F-HR | 4/23/2015, 05:01 PM |
| Q4 2014 | 5 | $105M | $0 | $0 | CLVSQ, FPRX, AKAOQ, CBAY, KYTH | Restatement | 4/23/2015, 04:13 PM |